• 1. Department of Neurological Intensive Care Unit, the First Affiliated Hospital of Sun Yat-Sen University, Guangzhou, 510080, P.R.China;
  • 2. Department of Breast and Thyroid Surgery, the First Affiliated Hospital of Sun Yat-Sen University, Guangzhou, 510080, P.R.China;
CHEN Ling, Email: chenl2@mail.sysu.edu.cn
Export PDF Favorites Scan Get Citation

Objectives To review the efficacy and safety of mechanical thrombectomy in patients with cerebral venous sinus thrombosis (CVST).Methods We searched The Cochrane Library, PubMed, EBSCO, Web of Science, CBM, CNKI and VIP databases to collect studies on mechanical thrombectomy in CVST patients from inception to April, 2018. Two reviewers independently screened literature, extracted the data and qualitative analysis of the included studies.Results A total of 33 studies including 552 patients were included for data analysis. Specifically, 157 (30%) patients had a focal neurological deficit, 145 (28%) patients had a pretreatment intracerebral hemorrhage or infarct, and 152 (29%) patients were stuporous or comatose. Wire was the most commonly used device. Overall, 483 (88%) patients had good outcome, while 35 (6%) patients deceased. Moreover, 333 (65%) patients had complete recanalization, 148 (29%) patients had partial recanalization, and 14 (2.5%) patients had worsen or new intracranial hemorrhage.Conclusions  The current evidence suggests that mechanical thrombectomy is reasonably safe in the majority of cases. Due to limited quality and quantity of included studies, more high quality studies are required to verify above studies.

Citation: ZHOU Hongyan, CHEANG Tuckyun, SUN Xunsha, SHEN Cunzhou, WANG Haiyan, FENG Li, CHEN Ling. Efficacy and safety of mechanical thrombectomy in cerebral venous sinus thrombosis: a literature review. Chinese Journal of Evidence-Based Medicine, 2019, 19(7): 836-843. doi: 10.7507/1672-2531.201802032 Copy

  • Previous Article

    Efficacy and safety of doxazosin for ureterolithiasis: a meta-analysis
  • Next Article

    Instruments designed for quality assessment of pharmaceutical economic evaluations: an overview